MetLife, Inc.
MET
$76.56
$0.230.30%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.84B | 4.29B | 4.50B | 4.43B | 3.76B |
| Total Depreciation and Amortization | 710.00M | 712.00M | 714.00M | 714.00M | 725.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.71B | 8.86B | 9.95B | 8.09B | 9.23B |
| Change in Net Operating Assets | 1.37B | 1.37B | 1.37B | 1.37B | 1.45B |
| Cash from Operations | 14.63B | 15.23B | 16.53B | 14.60B | 15.17B |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.69B | -13.83B | -12.19B | -11.49B | -5.55B |
| Cash from Investing | -16.69B | -13.83B | -12.19B | -11.49B | -5.55B |
| Total Debt Issued | 2.25B | 2.15B | 2.39B | 1.85B | 2.02B |
| Total Debt Repaid | -1.91B | -2.22B | -3.43B | -3.08B | -3.32B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.83B | -3.10B | -3.45B | -3.21B | -3.66B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -1.00B | -- | -- | -- | -- |
| Total Dividends Paid | -1.71B | -1.71B | -1.72B | -1.73B | -1.74B |
| Other Financing Activities | 5.84B | 4.89B | 3.56B | 3.03B | 3.91B |
| Cash from Financing | 642.00M | 4.00M | -2.65B | -3.13B | -2.79B |
| Foreign Exchange rate Adjustments | -116.00M | -12.00M | -208.00M | -545.00M | 25.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.53B | 1.39B | 1.49B | -571.00M | 6.85B |